# Emergent altermagnetism in (LaVO$_3$)$_n$/(LaNiO$_3$)$_m$ superlattices from interfacial charge transfer and octahedral tilts

Preprint · Gustavo H. Cassemiro, Walber H. Brito

- Archive id: arxiv:2610.30371
- Published: 2026-10-21
- arXiv: https://arxiv.org/abs/2610.30371
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.30371
- PDF: https://arxiv.org/pdf/2610.30371
- Provenance: arxiv

## Abstract

Using first-principles calculations, we show that altermagnetism emerges in (LaVO$\_3$)$\_n$/(LaNiO$\_3$)$\_m$ superlattices, with $(n,m) = (1,1), (2,2)$ and $(2,4)$, from the interplay of interfacial charge transfer and octahedral tilts. Charge transfer drives the system towards the V$^{4+}$ and Ni$^{2+}$ configuration, turning the otherwise paramagnetic nickelate layers into a magnetically active sublattice. The resulting $C$-type antiferromagnetic order, combined with $a^-b^+c^-$ or $a^-b^-c^-$ octahedral tilts, links opposite-spin sublattices only through nonsymmorphic operations, yielding a $d$-wave spin splitting without spin-orbit coupling. Within DFT+U, the splitting reaches 118 meV in the insulating (LVO)$\_1$/(LNO)$\_1$ superlattice, about twice that calculated for bulk LaVO$\_3$, and decreases as the nickelate layers become thicker. Our findings indicate that this splitting is hosted by both the V and Ni sublattices, with nearly half of its weight on oxygen $2p$ states through $p$-$d$ covalency. Interfacial charge transfer thus emerges as a \\textit{design} principle for engineering altermagnetism in oxide heterostructures.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Cuprates & the Pairing Mechanism](https://space-kitty.com/topics/cuprate-mechanism), [Nickelate & Iron-Based Superconductors](https://space-kitty.com/topics/nickelates-iron-based)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.